DGI
NVO

Disciplined Growth Investors’s Novo Nordisk NVO Stock Holding History

Disciplined Growth Investors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,558
Closed -$309K – 84
2022
Q1 		$309K Sell
5,558
-1,110
-17% -$57K 0.01% 86
2021
Q4 		$373K Buy
+6,668
New +$361K 0.01% 84

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Disciplined Growth Investors's NVO Position: Q2 2022 in Review

Disciplined Growth Investors sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 5,558 shares — an estimated $309K sold.

Disciplined Growth Investors first reported a position in NVO in Q4 2021 and held it in 2 quarters. The position peaked at $373K in Q4 2021. 934 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

  • Disciplined Growth Investors reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
  • Disciplined Growth Investors sold 5,558 Novo Nordisk shares in Q2 2022, an estimated $309K.
  • Disciplined Growth Investors first reported a position in Novo Nordisk in Q4 2021 and held it in 2 quarters.
  • Disciplined Growth Investors's Novo Nordisk position peaked at $373K in Q4 2021.
  • 934 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Disciplined Growth Investors's 13F filing for Q2 2022, filed 15 Aug 2022.